Nicholas Hertz, Montara Therapeutics CEO
July 30, 2024 07:00 AM EDT
Financing
Startups

Ex­clu­sive: Start­up aims to tack­le ‘un­drug­gable’ neu­ro tar­gets with tech from Ke­van Shokat's UCSF lab

Amber Tong

A year af­ter sell­ing their first neu­ro start­up to Ab­b­Vie, Ke­van Shokat and the for­mer PhD stu­dent he co-found­ed that com­pa­ny with are back with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Lasker Award goes to three sci­en­tists who pi­o­neered re­search be­hind GLP-1 drugs

FDA in­spec­tors dis­cov­er trucks car­ry­ing torn-up records leav­ing In­di­an gener­ics fac­to­ry

Ali­gos’ tri­al for oral MASH treat­ment suc­ceeds, but place­bo group shows odd trend

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

Stem cell start­up spun out of George Church’s lab rais­es $75M

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times